Stay updated with breaking news from Cue Cartridge Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The nucleic acid amplification test is the first at-home, over-the-counter test for COVID-19 to be granted marketing authorization using the traditional premarket review pathway.
The U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test.
With the emergence of Coronavirus infection called COVID-19, testing is essential for containment and mitigation purposes. In a pandemic, control is essential to limit the spread of any virus. Initially, contact tracing was not available which ultimately led to the 2020 pandemic. However, with the development of COVID-19 rapid testing, the rate of infections has lessened and has allowed for some return to normalcy. In this review, we discuss the various antibody, antigens, and molecular tests that have been given emergency authorization (EA) from the Food and Drug Administration (FDA). Moreov...
Cue Health rapid molecular test now offered at 900 of grocer’s Rx locations
/PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced its first airline partnership with Air Canada to provide...